Infectious Disease Research Center, CHU de Québec and Laval University, Quebec City, Quebec, Canada.
Department of Biochemistry, McGill University, Montreal, Quebec, Canada.
Vaccine. 2020 Feb 24;38(9):2122-2127. doi: 10.1016/j.vaccine.2020.01.047. Epub 2020 Jan 29.
Human metapneumovirus (hMPV) is an important respiratory pathogen especially in young children and elderly subjects. Our objective was to assess the immunogenicity and protection conferred by predominant pre- and post-fusion (F) hMPV-F constructs in Balb/C mice. Immunizations without adjuvant were not immunogenic whereas alum-adjuvanted hMPV-F proteins, regardless of their conformations, generated comparable neutralizing antibody titers with undetectable pulmonary viral titers following viral challenge. In conclusion, we found no apparent advantage for mixtures of predominant pre-fusion F proteins over post-fusion conformations for hMPV vaccination in opposite to recent data obtained with the human respiratory syncytial virus.
人偏肺病毒(hMPV)是一种重要的呼吸道病原体,尤其在婴幼儿和老年人群中更为常见。我们的目的是评估主要的前融合(pre-fusion)和后融合(post-fusion)(F)hMPV-F 结构在 Balb/C 小鼠中诱导的免疫原性和保护作用。无佐剂的免疫接种没有免疫原性,而铝佐剂的 hMPV-F 蛋白,无论其构象如何,在病毒攻毒后均可产生相当的中和抗体滴度,肺部病毒滴度无法检测到。总之,我们发现与最近从人类呼吸道合胞病毒获得的数据相反,对于 hMPV 疫苗接种,主要的前融合 F 蛋白混合物并没有比后融合构象明显的优势。